Stephen Gallagher

Stephen Gallagher is an accomplished financial executive with extensive experience in the pharmaceutical industry, currently serving as Vice President of Finance - Commercial at Intra-Cellular Therapies since April 2020. Previous roles include Vice President and CFO of Rx Pharmaceuticals at Perrigo, where financial leadership and strategic support were provided to the Rx division, and Vice President of Finance at Actavis, overseeing financial strategy for the Americas and leading a team of 50 associates. Gallagher has held significant financial positions in various companies, including Glenmark Pharmaceuticals, Pliva, Inc., Spring Air Partners, and GlaxoSmithKline, contributing expertise in areas such as financial reporting, treasury management, and risk management. Gallagher holds a Bachelor of Science degree in Accounting from Fairfield University.